249 articles in this topic
Analysis of 50,000+ tumors shows one-third of cancer drivers behave differently than expected, with major implications for treatment.
Liquid biopsy with next-generation sequencing shows promise for predicting glioma patient outcomes through circulating tumor DNA analysis.
New liquid biopsy technology identifies actionable cancer mutations in blood, enabling earlier detection and personalized treatment monitoring.
Breakthrough biosensors analyze blood and other fluids to detect cancer biomarkers, offering faster, less invasive diagnosis than traditional methods.
Surface proteins on tiny cellular packages could revolutionize early breast cancer detection through simple blood tests.
Comprehensive review reveals surgical and emerging biomarker approaches that significantly reduce cancer risk for women with Lynch syndrome.
Researchers are developing advanced liquid biopsies using AI to catch cancer early and monitor treatment response.
Liquid biopsies using circulating tumor DNA and cells may revolutionize early detection of breast cancer metastasis risk.
New CRISPR-based diagnostic tools could detect cancer biomarkers more accurately and affordably than current methods.
Revolutionary blood tests can detect breast cancer changes in real-time without invasive tissue biopsies.
New liquid biopsy analyzes DNA fragments in blood to detect breast cancer early, determine subtypes, and assess lymph node spread.
Revolutionary immune therapies and drug combinations are transforming bladder cancer treatment, offering unprecedented survival outcomes.
